Antibody against aflatoxin B1 was obtained after one multiple-site injection of bovine serum albumin-aflatoxin B1 conjugate into rabbits. The antibody has greatest binding efficiency for aflatoxin B1, less efficiency for B2, G1, and Q1, and least for aflatoxicol, G2, and M1. Sterigmatocystin, coumarin, and 4-hydroxycoumarin did not give a cross-reaction with the antibody. The sensitivity of the binding assay for detection of aflatoxin B1 is in the range of 0.2 to 2.0 ng per 0.5-ml sample. Detailed methods for the preparation of the conjugate, production of immune serum, and methods for antibody tiOr determination are described.
immune serum, and methods for antibody tiOr determination are described.
Aflatoxins are a group of toxic metabolites produced by Aspergillus flavus and Aspergillus parasiticus. Among this group of toxins, aflatoxin (Afla) B1 was found to be one of the most potent environmental carcinogens. The biological and toxicological properties of aflatoxin and the impact of this series of mycotoxins on human and animal health have been well documented (6, 7, 12) . Because of the widespread occurrence of toxin-producing fungi, and of the occurrence of the toxin in a number of agricultural commodities, efforts were made by various investigators to develop new methods for toxin detection. Methods for aflatoxin analysis used currently involve chemical analysis, biological assay, or a combination of both (6, 7, 11) . These methods, however, are either lacking in specificity or limited in sensitivity. More recently, Langone and Van Vunakis (8) described radioimmunoassays for aflatoxins and suggested that these assays were sufficiently sensitive and specific to determine the toxin in contaminated foodstuffs and biological samples. Along with our immunochemical studies on ochratoxins (3), we have also investigated the possibility of production of an antiserum specifically against aflatoxins using an approach different from that of Langone and Van Vunakis (8) . In this paper, details of the preparation of aflatoxin-protein conjugates and the method for antiserum production are described. The properties of the antibody obtained in our laboratory are compared with those of the antibody obtained by Langone and Van Vunakis (8) .
MATERIALS AND METHODS
Materials. Aflatoxins B,, B2, G, and G2 were prepared by the method of Chu (2) Antigens were prepared by conjugation of Afla B1-oxime with BSA or PL in the presence of EDPC. In a typical experiment, 10 mg of BSA in 1 ml of distilled water was added to 20 ml of Afla B1-oxime solution (6 mg of Afla B1-oxime in 25% ethanol-water) containing 376 mg of EDPC. The reaction mixture was stirred at room temperature, in complete darkness, for 48 h. Two additional 376-mg portions of EDPC were made to the reaction mixture during this period. After reaction, the mixture was dialyzed against 3 liters of distilled water and changed daily for 5 days. The final solution was passed through a membrane filter (Millipore Corp.) and kept frozen before being used for immunization. The amount of Afla B1-oxime conjugated to the BSA was determined by a spectrophotometric method using the molar absorptivity of 20,950 at 362 nm. Data obtained from both the unreacted toxin and the toxin conjugated to protein were used for final calculation.
Immunization schedule and antibody titer determination. For immunization, the multiple-site intradermal method of Nieschlag et al. (10) was followed, except that pertussis vaccine was omitted as an additional adjuvant in the initial immunization. In summary, a water-in-oil emulsion was prepared by using a sterilized Potter-Elvehjem type homogenizer and complete Freund adjuvant (1:2 to 1:3 [vol/ voll) but incorporating additional dried M. tuberculosis (20 mg per rabbit, or 10 mg per ml of emulsion). Sufficient antigen was dissolved in 0.9% NaCl solution, prior to making the emulsion, so that each milliliter of final emulsion would contain between 25 and 105 ,ug of protein (1.5 to 6 Ag of Afla B1). The back of each rabbit was shaved and 2 ml of the emulsion was injected intradermally into each rabbit at 20 to 40 sites along the shaved area. Trial bleedings via the marginal ear vein were made once every week, starting 3 weeks after immunization. Except when otherwise stated, no booster injections were made after initial injection.
For antibody titer determinations, a binding assay method was used (3). Antisera obtained from immunized rabbits were precipitated two times with (NH4)2S04 at a final saturation of 33.3%. The precipitate was redissolved in sufficient 0.02 M sodium phosphate buffer (NaPB), at pH 7.4, to give a volume equal to that of the original serum sample. Appropriate dilutions (at least four serial dilutions) of the preparation were made for binding studies. In general, 0.5 ml of each diluted antibody solution was dialyzed against 0.5 ml of 3H-labeled Afla B1 in 0.02 M NaPB, pH 7.4 (approximately 8,400 counts/min per 0.5 ml), in a cold room in complete darkness overnight. The radioactivities of 0.4-ml portions from both sides were counted after dialysis. The degree of binding was then determined. Antibody titer was defined as the reciprocal of the dilution which was required for 50% binding of 3H-labeled Afla B1 under the stated conditions. Determination of specificity of antibody against aflatoxins. The method for determining specificity of antibody against aflatoxin was essentially the same as those we have previously described for the immunochemical study for ochratoxins (3) . Immunoglobulin G (IgG) was purified from the antisera and was used in the equilibrium dialysis studies (3).
Three-tenths or five-tenths milliliter of IgG-3H-la- Determination of radioactivity and protein concentration. For radioactivity determination, an appropriate amount (in general less than 0.5 ml) of the test solution was mixed with 10 ml of Bray solution (1), and the radioactivity was counted in a Beckman model LS-330 liquid scintillation spectrometer. The protein concentration was determined by the Lowry method (9) using BSA as the protein standard.
RESULTS AND DISCUSSION Aflatoxins are low-molecular-weight, toxic fungal metabolites and thus are devoid of antigenicity. The toxins also lack a reactive group for the coupling of the toxin to a macromolecule carrier for antibody production. However, through derivation, a free carboxylic group is introduced to the toxin molecule, thus permitting the molecule to react covalently with proteins (Fig. 1) ml, respectively. Sterigmatocystin, coumarin, F 10 /l / l and 4-OH-coumarin had little or no effect on the binding of 3H-labeled Afla B, with IgG at the concentrations tested (up to 1,000 ng/ml). In the binding system described, the volume of the Ei 11 1 r sample tested varied between 0.3 and 0.5 ml. A e n _ 11 1 /total of 5,000 to 10,000 counts/min of radioactive z 11^// Afla B, was used. Therefore, the sensitivity for < 10 2
Afla B, detection in our system falls in the range of 0.2 to 2.0 ng. The sensitivity, however, can be improved by using higher-specific-activity 3H-labeled Afla B1. In the present study, a small amount of antigen has been shown to be sufficient for produc- (8) reported that aflatoxins B2, G1, and G2 inhibited the binding of 3H-labeled Afla B1 (determined at the 50% inhibition level) 2.3, 6.6, and 21 times less effectively than B1, but the present study, using the antibody produced from BSA-Afla B1, shows that aflatoxins B2, G1, and G2are 9, 11, and 89 times less effective. In addition, we found that the binding of two other major Afla B1 metabolites, namely aflatoxicol and aflatoxin M1, with the antibody varied considerably. Aflatoxicol, a metabolite formed by reduction of the carbonyl group in the cyclopentenone of Afla B1, binds about 40 times less than Afla B1; but aflatoxin M1, which is formed by hydroxylation at the 4 position in the dihydrofuran part of the Afla B1 structure, lost practically all of the binding capability. These results indicate conformation of aflatoxins greatly affecting their interaction with the antibody against Afla B1.
Whereas the antibody obtained in the present study is specific for Afla Bl, aflatoxins B2 and G1 also show some cross-reactivity at a concentration 10 
